Fibrinogen storage disease without hypofibrinogenaemia associated with acute infection

Histopathology

Volumn 42, Issue 1, 2003, Pages 22-25

  Marucci, G ^a   Morandi, L ^a   Macchia, S ^a   Betts, C M ^a   Tardio, M L ^a   Dal Monte, P R ^a   Pession, A ^a   Foschini, Maria Pia ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b BELLARIA HOSPITAL   (Italy)

Author keywords

Fibrinogen; Liver; Storage disease

Indexed keywords

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD CLOTTING TEST; CASE REPORT; CELL INCLUSION; CELL ULTRASTRUCTURE; CHRONIC HEPATITIS; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; EOSINOPHIL; FEMALE; FIBRINOGEN STORAGE DISEASE; GIANT CELL GRANULOMA; HUMAN; HYPOFIBRINOGENEMIA; IMMUNOHISTOCHEMISTRY; INFECTION; LABORATORY TEST; LIVER BIOPSY; LIVER FUNCTION TEST; PRIORITY JOURNAL; STORAGE DISEASE; TREATMENT OUTCOME;

ACUTE DISEASE; AFIBRINOGENEMIA; AGED; BRONCHOPNEUMONIA; COMMUNICABLE DISEASES; DIARRHEA; FEMALE; FIBRINOGEN; HEPATOCYTES; HUMANS; LIVER DISEASES;

BRESCIA;

EID: 0037227280     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2003.01551.x     Document Type: Article

References (12)

1. Callea F, Brisigotti M, Fabbretti G, Bonino F, Desmet VJ. Hepatic endoplasmic reticulum storage diseases. Liver 1992; 12; 357-362.
2. Pfeifer U, Ormanns W, Klinge O. Hepatocellular fibrinogen storage in familial hypofibrogenemia. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 1981; 36; 247-255.
3. Wehinger H, Klinge O, Alexandrakis E, Schurmann J, Witt J, Seydewitz HH. Hereditary hypofibrigenemia with storage disease in the liver. Eur. J. Pediatrics 1983; 141; 109-112.
4. Medicina D, Fabbretti G, Brennan SO, George PM, Kudryk B, Callea F. Genetic and immunological characterization of fibrinogen inclusion bodies in patients with hepatic fibrinogen storage and liver disease. Ann. NY Acad. Sci 2001; 936; 522-525.
5. Brennan SO, Wyatt J, Medicina D, Callea F, George PM. Fibrinogen Brescia: Hepatic endoplasmic reticulum storage and hypofibrogenaemia because of a gamma 284 Gly→Arg mutation. Am. J. Pathol. 2000; 157; 189-196.
6. Abukawa D, Tazawa Y, Noro T et al. Cytoplasmic inclusion bodies and minimal hepatitis: Fibrinogen storage without hypofibrogenaemia. Pediatr. Dev. Pathol. Jun 2001; 4; 304-309.
7. Foschini MP, Morandi L, Da Macchia SI, Monte PR, Pession A. TT virus related acute recurrent hepatitis. Histological features of a case and review of the literature. Virchows Arch. 2001; 439; 752-755.
8. Hashimoto K, Hoshii Y, Takahashi M et al. Use of monoclonal antibody against Lafora bodies for the immunocytochemical study of ground-glass inclusions in hepatocytes due to cyanamide. Histopathology 2001; 39; 60-65.
9. Vazquez JJ. Ground-glass hepatocytes: Light and electron microscopy. Characterization of the different types. Histol. Histopathol 1990; 5; 379-386.
10. Nakashima O, Sugihara S, Eguchi A, Taguchi J, Watanabe J, Kojiro M. Pathomorphologic study of pale bodies in hepatocellular carcinoma. Acta Pathol. Jpn. 1992; 42; 414-418.
11. Johnson HL, Chiou CC, Cho CT. Applications of acute phase reactants in infectious diseases. J. Microbiol. Immunol. Infect. 1999; 32; 73-82.
12. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 1999; 340; 448-454.